SENSEX NIFTY

Religare Capital Markets

Oct 31, 2014 at 22:14 | Source: CNBC-TV18
The markets are back on a steroid-run and the rally has more legs, says Arshad Zakaria of New Vernon Capital. Zakaria is one of the most influential voices and he has served as the executive of Merrill Lynch. In an exclusive conversation with CNBC-TV18s Latha Venkatesh, he explained why sky is the limit for Indian equities.
Oct 31, 2014 at 20:53 | Source: CNBC-TV18
In an interview, market expert Saurabh Mukherjee talks about his book, Gurus of Chaos, on India's top money masters, and what it takes to succeed in the Indian market and at investing in general.
Oct 31, 2014 at 16:29 | Source: CNBC-TV18
GCM Securities is a company that listed in May 2013 and it has gained 4,000% since listing. Market capital of the company is Rs 1,643 cr.
Oct 31, 2014 at 15:28 | Source: Moneycontrol.com
Arihant capital markets is bullish on UltraTech Cement and has recommended accumulate rating on the stock with a target of Rs 2872 in its October 21, 2014 research report.
Oct 31, 2014 at 15:27 | Source: Moneycontrol.com
Religare Capital is bullish on Oriental Bank of Commerce and has recommended buy rating on the stock with a target of Rs 380 in its October 29, 2014 research report.
Oct 31, 2014 at 15:23 | Source: Moneycontrol.com
Religare Capital is bullish on Shriram Transport Finance Corporation and has recommended buy rating on the stock with a target of Rs 1100 in its October 29, 2014 research report.
Oct 31, 2014 at 14:17 | Source: Moneycontrol.com
Arihant capital markets has recommended a neutral rating on Hero Motocorp with a target price of Rs 2970, in its research report dated October 17, 2014.
Oct 31, 2014 at 14:16 | Source: Moneycontrol.com
Religare Capital has recommended hold rating on Havells India with a target price of Rs 260, in its research report dated October 22, 2014.
Oct 30, 2014 at 19:52 | Source: CNBC-TV18
Mangesh Bhadang, Research Analyst, Quant Capital is a tad disappointed on the topline and PAT front and see limited upside for the stock. He would buy on dips and advices current investors to hold on.
Oct 30, 2014 at 18:15 | Source: Moneycontrol.com
Religare Capital is bearish on Hindustan Unilever (HUL) and has recommended sell rating on the stock with a target of Rs 660 in its October 27, 2014 research report.
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

247140 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th

cleverman

Platinum Member

92 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th

BSE/NSE Announcer

Platinum Member

4826 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th

Web Messenger

Platinum Member

247140 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

247140 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

247140 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

247140 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

News across the web »
Jul 08, 2014 at 07:59 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.